Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

401 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Tumour vascular targeting.
Neri D, Bicknell R. Neri D, et al. Among authors: bicknell r. Nat Rev Cancer. 2005 Jun;5(6):436-46. doi: 10.1038/nrc1627. Nat Rev Cancer. 2005. PMID: 15928674 Review.
Antibody targeting of cathepsin S inhibits angiogenesis and synergistically enhances anti-VEGF.
Ward C, Kuehn D, Burden RE, Gormley JA, Jaquin TJ, Gazdoiu M, Small D, Bicknell R, Johnston JA, Scott CJ, Olwill SA. Ward C, et al. Among authors: bicknell r. PLoS One. 2010 Sep 2;5(9):e12543. doi: 10.1371/journal.pone.0012543. PLoS One. 2010. PMID: 20824056 Free PMC article.
Anticancer strategies involving the vasculature.
Heath VL, Bicknell R. Heath VL, et al. Among authors: bicknell r. Nat Rev Clin Oncol. 2009 Jul;6(7):395-404. doi: 10.1038/nrclinonc.2009.52. Epub 2009 May 7. Nat Rev Clin Oncol. 2009. PMID: 19424102 Review.
Therapeutic targeting of the tumor vasculature.
Tozer GM, Bicknell R. Tozer GM, et al. Among authors: bicknell r. Semin Radiat Oncol. 2004 Jul;14(3):222-32. doi: 10.1016/j.semradonc.2004.04.009. Semin Radiat Oncol. 2004. PMID: 15254865 Review.
The development of [(124)I]iodinated-VG76e: a novel tracer for imaging vascular endothelial growth factor in vivo using positron emission tomography.
Collingridge DR, Carroll VA, Glaser M, Aboagye EO, Osman S, Hutchinson OC, Barthel H, Luthra SK, Brady F, Bicknell R, Price P, Harris AL. Collingridge DR, et al. Among authors: bicknell r. Cancer Res. 2002 Oct 15;62(20):5912-9. Cancer Res. 2002. PMID: 12384557
Adrenomedullin and tumour angiogenesis.
Nikitenko LL, Fox SB, Kehoe S, Rees MC, Bicknell R. Nikitenko LL, et al. Among authors: bicknell r. Br J Cancer. 2006 Jan 16;94(1):1-7. doi: 10.1038/sj.bjc.6602832. Br J Cancer. 2006. PMID: 16251875 Free PMC article. Review.
Controlling the vasculature: angiogenesis, anti-angiogenesis and vascular targeting of gene therapy.
Fan TP, Jaggar R, Bicknell R. Fan TP, et al. Among authors: bicknell r. Trends Pharmacol Sci. 1995 Feb;16(2):57-66. doi: 10.1016/s0165-6147(00)88979-8. Trends Pharmacol Sci. 1995. PMID: 7539171 Review.
Cooperative stimulation of vascular endothelial growth factor expression by hypoxia and reactive oxygen species: the effect of targeting vascular endothelial growth factor and oxidative stress in an orthotopic xenograft model of bladder carcinoma.
Brown NS, Streeter EH, Jones A, Harris AL, Bicknell R. Brown NS, et al. Among authors: bicknell r. Br J Cancer. 2005 May 9;92(9):1696-701. doi: 10.1038/sj.bjc.6602522. Br J Cancer. 2005. PMID: 15841086 Free PMC article.
Vascular endothelial growth factor is a predictor of relapse and stage progression in superficial bladder cancer.
Crew JP, O'Brien T, Bradburn M, Fuggle S, Bicknell R, Cranston D, Harris AL. Crew JP, et al. Among authors: bicknell r. Cancer Res. 1997 Dec 1;57(23):5281-5. Cancer Res. 1997. PMID: 9393750
Breast cancer angiogenesis--new approaches to therapy via antiangiogenesis, hypoxic activated drugs, and vascular targeting.
Harris AL, Zhang H, Moghaddam A, Fox S, Scott P, Pattison A, Gatter K, Stratford I, Bicknell R. Harris AL, et al. Among authors: bicknell r. Breast Cancer Res Treat. 1996;38(1):97-108. doi: 10.1007/BF01803788. Breast Cancer Res Treat. 1996. PMID: 8825127 Review.
401 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback